Dr. David Huntsman awarded Doctors of BC Terry Fox Medal
Pictured above is Dr. Huntsman in St. Johns Newfoundland, near the place where Terry Fox began his run.
News
From research to practice: Empowering oncology nurses in advance care planning
A new study from BC Cancer researchers explores how to better support oncology nurses in engaging patients and families in advance care planning (ACP).
Dr. Christian Steidl receives AstraZeneca and Leukemia & Lymphoma Society Grant
Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.
The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.
Dr. Alexander Wyatt appointed UBC President’s Excellence Chair in Precision Oncology
BC Cancer senior scientist, Dr. Alexander Wyatt, has been appointed the UBC President’s Excellence Chair in Precision Oncology by the UBC Faculty of Medicine.
Studying six childhood sarcomas to improve survival and life after treatment
With renewed support from a $5.5-million Terry Fox New Frontiers Program Project Grant, leading researchers from BC Cancer and the University of British Columbia (UBC) are determined to change how we understand and treat sarcomas – rare and aggressive bone and soft tissue cancers that disproportionately affect young people.
BC Cancer researchers receive 2025 Research Trainee Awards from Michael Smith Health Research BC
Two Postdoctoral Fellows in the Evgin Lab at the BC Cancer Research Institute are the recipients of the 2025 Research Trainee Awards from Michael Smith Health Research BC.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.